Carr Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$820K Buy
3,356
+444
+15% +$103K 0.22% 74
2025
Q4
$603K Buy
2,912
+5
+0.2% +$989 0.16% 93
2025
Q3
$539K Sell
2,907
-596
-17% -$102K 0.15% 95
2025
Q2
$535K Buy
3,503
+20
+0.6% +$3.07K 0.16% 92
2025
Q1
$578K Sell
3,483
-4
-0.1% -$626 0.19% 82
2024
Q4
$504K Sell
3,487
-541
-13% -$83.8K 0.16% 96
2024
Q3
$653K Buy
4,028
+543
+16% +$86.5K 0.19% 89
2024
Q2
$509K Buy
3,485
+19
+0.5% +$2.83K 0.16% 107
2024
Q1
$548K Sell
3,466
-377
-10% -$60K 0.18% 96
2023
Q4
$602K Buy
3,843
+7
+0.2% +$1.07K 0.22% 75
2023
Q3
$581K Sell
3,836
-219
-5% -$36.1K 0.23% 77
2023
Q2
$671K Sell
4,055
-83
-2% -$13.4K 0.27% 67
2023
Q1
$641K Sell
4,138
-238
-5% -$38.4K 0.28% 72
2022
Q4
$773K Buy
+4,376
New +$756K 0.41% 55

Other funds holding JNJ

Carr Financial Group's JNJ Position: Q1 2026 in Review

Carr Financial Group increased its Johnson & Johnson (JNJ) stake by 15% in Q1 2026, buying an estimated $103K and bringing the position to 3,356 shares worth $820K. The position accounts for 0.22% of the portfolio, ranked #74.

Carr Financial Group first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Carr Financial Group held 3,356 shares of Johnson & Johnson worth $820K as of Q1 2026.
  • Carr Financial Group bought 444 Johnson & Johnson shares in Q1 2026, an estimated $103K.
  • Johnson & Johnson made up 0.22% of Carr Financial Group's portfolio in Q1 2026, its #74 holding.
  • Carr Financial Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Carr Financial Group's 13F filing for Q1 2026, filed 12 May 2026.